-
Posted by
Two Blokes Jun 16 -
Filed in
Stock
-
6 views
LOUISVILLE, Ky., June 16, 2025 (GLOBE NEWSWIRE) -- Onco360\u00ae, the nation's leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Nuvation Bio Inc. for IBTROZI\u2122 (taletrectinib), a kinase inhibitor approved for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC)1. This indication was approved based on the Phase 2 TRUST-I and TRUST-II studies of taletrectinib that enrolled over 300 patients with ROS1-positive NSCLC.2 ,3
